Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma

References

• Toomey EC, Schiffman JD, Lessnick SL. Recent advances in the molecular pathogenesis of Ewing’s sarcoma. Oncogene 2010; 29:4504 - 16; http://dx.doi.org/10.1038/onc.2010.205; PMID: 20543858
   PubMed Web of Science ®Google Scholar
• Shukla N, Schiffman J, Reed D, Davis IJ, Womer RB, Lessnick SL, Lawlor ER, COG Ewing Sarcoma Biology Committee. Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children’s Oncology Group. Front Oncol 2013; 3:141; PMID: 23761859
   PubMedGoogle Scholar
• Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679 - 92; http://dx.doi.org/10.1038/nrg3270; PMID: 22945394
   PubMed Web of Science ®Google Scholar
• Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343:1350 - 4; http://dx.doi.org/10.1056/NEJM200011093431901; PMID: 11070098
   PubMed Web of Science ®Google Scholar
• Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008; 358:1118 - 28; http://dx.doi.org/10.1056/NEJMoa0706550; PMID: 18337602
   PubMed Web of Science ®Google Scholar
• Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97:1124 - 32; http://dx.doi.org/10.1093/jnci/dji204; PMID: 16077070
   PubMed Web of Science ®Google Scholar
• Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Markowitz S, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008; 103:2862 - 70; http://dx.doi.org/10.1111/j.1572-0241.2008.02088.x; PMID: 18759824
   PubMed Web of Science ®Google Scholar
• Gharanei S, Brini AT, Vaiyapuri S, Alholle A, Dallol A, Arrigoni E, Kishida T, Hiruma T, Avigad S, Grimer R, et al. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. Epigenetics 2013; 8; In press http://dx.doi.org/10.4161/epi.25617; PMID: 23887284
   PubMed Web of Science ®Google Scholar
• Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 2005; 65:4598 - 606; http://dx.doi.org/10.1158/0008-5472.CAN-04-3371; PMID: 15930277
   PubMed Web of Science ®Google Scholar
• Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F, Maher ER. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 2010; 29:2104 - 17; http://dx.doi.org/10.1038/onc.2009.493; PMID: 20154727
   PubMed Web of Science ®Google Scholar
• Wang P, Wang YC, Chen XY, Shen ZY, Cao H, Zhang YJ, Yu J, Zhu JD, Lu YY, Fang JY. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer. Cancer Sci 2012; 103:1327 - 33; http://dx.doi.org/10.1111/j.1349-7006.2012.02292.x; PMID: 22590977
   PubMed Web of Science ®Google Scholar
• Mahoney SE, Yao Z, Keyes CC, Tapscott SJ, Diede SJ. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas. Epigenetics 2012; 7:400 - 8; http://dx.doi.org/10.4161/epi.19463; PMID: 22419069
   PubMed Web of Science ®Google Scholar
• Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, Herman JG. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene 2010; 29:5923 - 34; http://dx.doi.org/10.1038/onc.2010.322; PMID: 20697356
   PubMed Web of Science ®Google Scholar
• Ohali A, Avigad S, Cohen IJ, Meller I, Kollender Y, Issakov J, Goshen Y, Yaniv I, Zaizov R. High frequency of genomic instability in Ewing family of tumors. Cancer Genet Cytogenet 2004; 150:50 - 6; http://dx.doi.org/10.1016/j.cancergencyto.2003.08.014; PMID: 15041223
   PubMed Web of Science ®Google Scholar
• Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, Huang Y, Yamashita K, Trink B, Ratovitski EA, Sidransky D. Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS One 2010; 5:e9003; http://dx.doi.org/10.1371/journal.pone.0009003; PMID: 20140245
   PubMedGoogle Scholar
• Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003; 63:3735 - 42; PMID: 12839967
   PubMed Web of Science ®Google Scholar
• Park JK, Ryu JK, Yoon WJ, Lee SH, Lee GY, Jeong KS, Kim YT, Yoon YB. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Pancreas 2012; 41:95 - 101; http://dx.doi.org/10.1097/MPA.0b013e318221c903; PMID: 21778928
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao J, Li L, Li Z, Du Y, Gong Y. The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro. Mol Biol Rep 2011; 38:4903 - 11; http://dx.doi.org/10.1007/s11033-010-0632-y; PMID: 21161403
   PubMed Web of Science ®Google Scholar
• Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Mol Cancer Res 2008; 6:592 - 603; http://dx.doi.org/10.1158/1541-7786.MCR-07-0154; PMID: 18403638
   PubMed Web of Science ®Google Scholar
• Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, et al. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab 2012; 97:E1004 - 13; http://dx.doi.org/10.1210/jc.2011-3298; PMID: 22472567
   PubMed Web of Science ®Google Scholar
• Fernandez-Ranvier GG, Weng J, Yeh RF, Khanafshar E, Suh I, Barker C, Duh QY, Clark OH, Kebebew E. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg 2008; 143:841 - 6, discussion 846; http://dx.doi.org/10.1001/archsurg.143.9.841; PMID: 18794420
   PubMed Web of Science ®Google Scholar
• Yamada T, Kayashima T, Yamasaki K, Ohta T, Yoshiura Ki, Matsumoto N, Fujimoto S, Niikawa N, Kishino T. The gene TSGA14, adjacent to the imprinted gene MEST, escapes genomic imprinting. Gene 2002; 288:57 - 63; http://dx.doi.org/10.1016/S0378-1119(02)00428-6; PMID: 12034494
   PubMed Web of Science ®Google Scholar
• Avigad S, Shukla S, Naumov I, Cohen IJ, Ash S, Meller I, Kollender Y, Issakov J, Yaniv I. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma. Pediatr Blood Cancer 2009; 53:1023 - 8; http://dx.doi.org/10.1002/pbc.22115; PMID: 19637319
   PubMed Web of Science ®Google Scholar
• Ricketts CJ, Morris MR, Gentle D, Brown M, Wake N, Woodward ER, Clarke N, Latif F, Maher ER. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma. Epigenetics 2012; 7:278 - 90; http://dx.doi.org/10.4161/epi.7.3.19103; PMID: 22430804
   PubMed Web of Science ®Google Scholar